During the past decades, anticancer immunotherapy has evolved from a promising therapeutic
option to a robust clinical reality. Many immunotherapeutic regimens are now approved …

The current COVID-19 pandemic challenges oncologists to profoundly re-organize
oncological care in order to dramatically reduce hospital visits and admissions and therapy-induced …

Surgery is the only potential hope of cure for patients with pancreatic cancer. Advantageous
tumour characteristics and complete tumour resection are the factors most relevant for a …

Background Australia has successfully controlled the COVID-19 pandemic. Similar to other
high-income countries, Australia has extensively used telehealth services. Virtual health care…

Background Treatments for small-cell lung cancer (SCLC) after failure of platinum-based
chemotherapy are limited. We assessed safety and activity of nivolumab and nivolumab plus …

The primary objective of the insteady aerodynamics experiment was to provide information
needed to quantify the full-scale, three-dimensional aerodynamic behavior of horizontal-axis …

A growing number of human tumor antigens have been described that can be recognized
by cytotoxic T lymphocytes (CTLs) in a major histocompatibility complex (MHC) class I–…

… This is a potential operational advantage, as observed between prostate-specific membrane
antigen targeting with the antibody J591 and an optimal imaging after 6–8 d (28) versus low-…

Inefficient T cell migration is a major limitation of cancer immunotherapy. Targeted activation
of the tumor microenvironment may overcome this barrier. We demonstrate that …

METHODS This phase II open-label study involved 128 centers worldwide. Eligible patients
were age≥ 18 years and had metastatic MSI-H/dMMR CRC treated with≥ 2 prior lines of …